Understanding and preparing for clinical drug trial audits

American Journal of Health-System Pharmacy

Volumn 59, Issue 23, 2002, Pages

  Siden, Rivka ^a   Tankanow, Roberta M ^a   Tamer, Helen R ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOAVAILABILITY; CLINICAL PRACTICE; DRUG SCREENING; FOOD AND DRUG ADMINISTRATION; MEDICAL AUDIT; MEDICAL RECORD; MEDICAL RESEARCH; NOTE; PRIORITY JOURNAL; QUALITY CONTROL;

EID: 0036995805     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/59.23.2301     Document Type: Note

References (11)

1. Food and Drug Administration. Institutional review board inspections. IRB operations and clinical investigation information sheet. www.fda.gov/oc/ohrt/irbs/operations.html (accessed 2002 May 15).
2. Food and Drug Administration. International Conference on Harmonization; Good Clinical Practice consolidated guidelines. Fed Regist. 1997;62:25692-709.
3. National Cancer Institute. Investigator's handbook. Part 16.5. http//ctep.cancer. gov/forms/Hndbk.pdf (accessed 2002 May 5).
4. Anticipating an audit. In: Ginsberg D, ed. The investigator's guide to clinical research. 2nd ed. Boston: CenterWatch, Inc.; 1999:153-6.
5. FDA inspections. In: Iber FL, Riley WA, Murray PJ, eds. Conducting clinical trials. New York: Plenum Medical; 1987:315-23.
6. Curran CF. Preparing a clinical site for a clinical investigator inspection by the FDA. Drug Inf J. 1999; 33:253-6.
7. 21 C.F.R. 312.59.
8. 21 C.F.R. 312.61.
9. 21 C.F.R. 312.62.
10. Guidelines on clinical drug research. In: Deffenbaugh JH, ed. Best practices for health-system pharmacy: position and guidance documents of ASHP 2001-2002. Bethesda, MD: American Society of Health-System Pharmacists; 2002:294-300.
11. Food and Drug Administration. Compliance program guidance. Manual for FDA staff. Part III - inspectional. www.fda.gov/ora/compliance_ref/bimo/7348_811 (accessed 2002 May 5).